These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12686105)

  • 21. Glutamate decarboxylase inhibition and vitamin B6 metabolism in brain of cirrhotic rats chronically treated with carbon tetrachloride.
    Díaz-Muñoz M; Tapia R
    J Neurosci Res; 1988 Jul; 20(3):376-82. PubMed ID: 3225873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridoxol metabolism in vitamin B6-responsive convulsions of early infancy.
    Heeley A; Pugh RJ; Clayton BE; Shepherd J; Wilson J
    Arch Dis Child; 1978 Oct; 53(10):794-802. PubMed ID: 727793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-compliance in pyridoxine-dependent seizures and a way out.
    Kumar P; Gupta VK; Mishra D
    J Paediatr Child Health; 2007; 43(7-8):571-2. PubMed ID: 17635690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pyridoxine or pyridoxal phosphate for intractable seizures?
    Baxter P
    Arch Dis Child; 2005 May; 90(5):441-2. PubMed ID: 15851419
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene.
    Plecko B; Paul K; Paschke E; Stoeckler-Ipsiroglu S; Struys E; Jakobs C; Hartmann H; Luecke T; di Capua M; Korenke C; Hikel C; Reutershahn E; Freilinger M; Baumeister F; Bosch F; Erwa W
    Hum Mutat; 2007 Jan; 28(1):19-26. PubMed ID: 17068770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seizures and paroxysmal events: symptoms pointing to the diagnosis of pyridoxine-dependent epilepsy and pyridoxine phosphate oxidase deficiency.
    Schmitt B; Baumgartner M; Mills PB; Clayton PT; Jakobs C; Keller E; Wohlrab G
    Dev Med Child Neurol; 2010 Jul; 52(7):e133-42. PubMed ID: 20370816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyridoxine-dependent seizures: a case report and a critical review of the literature.
    Gupta VK; Mishra D; Mathur I; Singh KK
    J Paediatr Child Health; 2001 Dec; 37(6):592-6. PubMed ID: 11903843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridoxal phosphate-responsive epilepsy with resistance to pyridoxine.
    Kuo MF; Wang HS
    Pediatr Neurol; 2002 Feb; 26(2):146-7. PubMed ID: 11897481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry.
    Basura GJ; Hagland SP; Wiltse AM; Gospe SM
    Eur J Pediatr; 2009 Jun; 168(6):697-704. PubMed ID: 18762976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in antiquitin in individuals with pyridoxine-dependent seizures.
    Mills PB; Struys E; Jakobs C; Plecko B; Baxter P; Baumgartner M; Willemsen MA; Omran H; Tacke U; Uhlenberg B; Weschke B; Clayton PT
    Nat Med; 2006 Mar; 12(3):307-9. PubMed ID: 16491085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Typical and atypical phenotypes of PNPO deficiency with elevated CSF and plasma pyridoxamine on treatment.
    Ware TL; Earl J; Salomons GS; Struys EA; Peters HL; Howell KB; Pitt JJ; Freeman JL
    Dev Med Child Neurol; 2014 May; 56(5):498-502. PubMed ID: 24266778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of pyridoxine dependent and pyridoxine responsive seizures in the UK.
    Baxter P
    Arch Dis Child; 1999 Nov; 81(5):431-3. PubMed ID: 10519720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seizures with decreased levels of pyridoxal phosphate in cerebrospinal fluid.
    Goyal M; Fequiere PR; McGrath TM; Hyland K
    Pediatr Neurol; 2013 Mar; 48(3):227-31. PubMed ID: 23419474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxine dependent epilepsy and antiquitin deficiency: clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up.
    Stockler S; Plecko B; Gospe SM; Coulter-Mackie M; Connolly M; van Karnebeek C; Mercimek-Mahmutoglu S; Hartmann H; Scharer G; Struijs E; Tein I; Jakobs C; Clayton P; Van Hove JL
    Mol Genet Metab; 2011; 104(1-2):48-60. PubMed ID: 21704546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsy.
    Kure S; Sakata Y; Miyabayashi S; Takahashi K; Shinka T; Matsubara Y; Hoshino H; Narisawa K
    J Hum Genet; 1998; 43(2):128-31. PubMed ID: 9621518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyridoxine-dependent seizures.
    Crowell GF; Roach ES
    Am Fam Physician; 1983 Mar; 27(3):183-7. PubMed ID: 6829389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy.
    Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY
    Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on interconversions of vitamin B-6 with its coenzyme.
    McCormick DB; Chen H
    J Nutr; 1999 Feb; 129(2):325-7. PubMed ID: 10024608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyridoxal 5'-phosphate (PLP) deficiency might contribute to the onset of type I diabetes.
    Rubí B
    Med Hypotheses; 2012 Jan; 78(1):179-82. PubMed ID: 22088923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyridoxine or pyridoxal-5-phosphate treatment for seizures in glycosylphosphatidylinositol deficiency: A cohort study.
    Bayat A; Aledo-Serrano A; Gil-Nagel A; Korff CM; Thomas A; Boßelmann C; Weber Y; Gardella E; Lund AM; de Sain-van der Velden MGM; Møller RS
    Dev Med Child Neurol; 2022 Jun; 64(6):789-798. PubMed ID: 35080266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.